Convenient production of a novel recombinant antibody against periodontitis biomarker S100A8
S100A8 serves as a biomarker for periodontitis and is involved in inflammatory processes, making its detection highly important. In this study, we produced recombinant 5A11 (r5A11) through mammalian cell culture. By employing a three-step process of transfection, suspension cell culture, and purification, we conveniently produced r5A11 with high yield and purity. The limit of detection for the r5A11-based immunoassay was 1.7 ± 0.2 × 10<sup>-1 </sup>ng/mL, which was higher than that of the commercially available anti-S100A8 antibody. These findings suggest the potential use of this novel antibody in various research applications and practical approaches for simple and sensitive S100A8 detection.
Authors
- Hui-Seon Yun
- Byung‐Gee Kim (ORCID: https://orcid.org/0000-0002-3776-1001)
- Hee-Jin Jeong (ORCID: https://orcid.org/0000-0002-8433-4547)
- Eun-Jung Kim (ORCID: https://orcid.org/0000-0001-6727-1065)
Institutions
- Io Therapeutics (United States) (US)
- Hongik University (KR)
Publication Details
- Journal
- Preparative Biochemistry & Biotechnology
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1080/10826068.2024.2430615
- Primary Topic
- S100 Proteins and Annexins
- Type
- article
- Field-Weighted Citation Impact
- 0.00